{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:21:56Z","timestamp":1785280916474,"version":"3.55.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI104488-01A1"],"award-info":[{"award-number":["R01 AI104488-01A1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000056","name":"National Institute of Nursing Research","doi-asserted-by":"publisher","award":["F31 NR016910-01A1"],"award-info":[{"award-number":["F31 NR016910-01A1"]}],"id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Individuals treated for drug-resistant tuberculosis (DR-TB) with aminoglycosides (AGs) in resource-limited settings often experience permanent hearing loss, yet there is no practical method to identify those at higher risk. We sought to develop a clinical prediction model of AG-induced hearing loss among patients initiating DR-TB treatment in South Africa.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Using nested, prospective data from a cohort of 379 South African adults being treated for confirmed DR-TB with AG-based regimens we developed the prediction model using multiple logistic regression. Predictors were collected from clinical, audiological, and laboratory evaluations conducted at the initiation of DR-TB treatment. The outcome of AG-induced hearing loss was identified from audiometric and clinical evaluation by a worsened hearing threshold compared with baseline during the 6-month intensive phase.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Sixty-three percent of participants (n = 238) developed any level of hearing loss. The model predicting hearing loss at frequencies from 250 to 8000 Hz included weekly AG dose, human immunodeficiency virus status with CD4 count, age, serum albumin, body mass index, and pre-existing hearing loss. This model demonstrated reasonable discrimination (area under the receiver operating characteristic curve [AUC] = 0.71) and calibration (\u03c72[8] = 6.10, P = .636). Using a cutoff of 80% predicted probability of hearing loss, the positive predictive value of this model was 83% and negative predictive value was 40%. Model discrimination was similar for ultrahigh-frequency hearing loss (frequencies &amp;gt;9000 Hz; AUC = 0.81) but weaker for clinically determined hearing loss (AUC = 0.60).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This model may identify patients with DR-TB who are at highest risk of developing AG-induced ototoxicity and may help prioritize patients for AG-sparing regimens in clinical settings where access is limited.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciz289","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T19:46:30Z","timestamp":1554407190000},"page":"917-924","source":"Crossref","is-referenced-by-count":17,"title":["Aminoglycoside-induced Hearing Loss Among Patients Being Treated for Drug-resistant Tuberculosis in South Africa: A Prediction Model"],"prefix":"10.1093","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3141-7506","authenticated-orcid":false,"given":"Hyejeong","family":"Hong","sequence":"first","affiliation":[{"name":"Johns Hopkins University School of Nursing, Baltimore, Maryland"},{"name":"The Research Education Advocacy Community Health Initiative, Johns Hopkins University School of Nursing, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W","family":"Dowdy","sequence":"additional","affiliation":[{"name":"Departments of Epidemiology, and International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly E","family":"Dooley","sequence":"additional","affiliation":[{"name":"Divisions of Clinical Pharmacology and Infectious Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard W","family":"Francis","sequence":"additional","affiliation":[{"name":"Division of Head and Neck Surgery and Communication Sciences, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chakra","family":"Budhathoki","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Nursing, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae-Ra","family":"Han","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Nursing, Baltimore, Maryland"},{"name":"Center for Cardiovascular and Chronic Care, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason E","family":"Farley","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Nursing, Baltimore, Maryland"},{"name":"The Research Education Advocacy Community Health Initiative, Johns Hopkins University School of Nursing, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"key":"2020082913520932700_CIT0001","author":"World Health Organization"},{"key":"2020082913520932700_CIT0002","author":"World Health Organization"},{"key":"2020082913520932700_CIT0003","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.5588\/ijtld.13.0075","article-title":"High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses","volume":"18","author":"Piubello","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"2020082913520932700_CIT0004","doi-asserted-by":"crossref","first-page":"517","DOI":"10.5588\/ijtld.14.0535","article-title":"High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon","volume":"19","author":"Kuaban","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"2020082913520932700_CIT0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5588\/ijtld.17.0498","article-title":"Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries","volume":"22","author":"Tr\u00e9bucq","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"2020082913520932700_CIT0006","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa1811867","article-title":"A trial of a shorter regimen for rifampin-resistant tuberculosis","volume":"380","author":"Nunn","year":"2019","journal-title":"N Engl J Med"},{"key":"2020082913520932700_CIT0007","doi-asserted-by":"crossref","first-page":"937861","DOI":"10.1155\/2011\/937861","article-title":"Mechanisms of aminoglycoside ototoxicity and targets of hair cell pr","volume":"2011","author":"Huth","year":"2011","journal-title":"Int J Otolaryngol"},{"key":"2020082913520932700_CIT0008","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1365-2125.2001.00088.x","article-title":"Therapeutic drug monitoring in a developing country: an overview","volume":"52","author":"Gogtay","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"2020082913520932700_CIT0009","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/lary.25848","article-title":"Quality of life after intervention with a cochlear implant or hearing aid","volume":"126","author":"Contrera","year":"2016","journal-title":"Laryngoscope"},{"key":"2020082913520932700_CIT0010","first-page":"S43","article-title":"Cochlear implantation: a personal and societal economic perspective examining the effects of cochlear implantation on personal income","volume":"41","author":"Monteiro","year":"2012","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"2020082913520932700_CIT0011","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/014556131209100103","article-title":"Hearing loss: economic impact","volume":"91","author":"Sataloff","year":"2012","journal-title":"Ear Nose Throat J"},{"key":"2020082913520932700_CIT0012","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/000348941212101201","article-title":"Association of hearing loss with decreased employment and income among adults in the United States","volume":"121","author":"Jung","year":"2012","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"2020082913520932700_CIT0013","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000448352","article-title":"Treatment for hearing loss among the elderly: auditory outcomes and impact on quality of life","volume":"21","author":"Manrique-Huarte","year":"2016","journal-title":"Audiol Neurootol"},{"key":"2020082913520932700_CIT0014","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/lary.25568","article-title":"Cochlear implantation in children with unilateral hearing loss: a systematic review","volume":"126","author":"Peters","year":"2016","journal-title":"Laryngoscope"},{"key":"2020082913520932700_CIT0015","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3109\/14992027.2016.1166397","article-title":"Development and psychometric evaluation of a health-related quality of life instrument for individuals with adult-onset hearing loss","volume":"55","author":"Stika","year":"2016","journal-title":"Int J Audiol"},{"key":"2020082913520932700_CIT0016","doi-asserted-by":"crossref","first-page":"667","DOI":"10.5588\/ijtld.17.0830","article-title":"Increased risk of aminoglycoside-induced hearing loss in MDR-TB patients with HIV coinfection","volume":"22","author":"Hong","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"2020082913520932700_CIT0017","volume-title":"Mid-year population estimates, 2015: HIV prevalence estimates and the number of people living with HIV","author":"Statistics South Africa","year":"2015"},{"key":"2020082913520932700_CIT0018","first-page":"540","article-title":"Gentamicin-induced ototoxicity in a carefully monitored renal-failure patient","volume":"38","author":"Crass","year":"1981","journal-title":"Am J Hosp Pharm"},{"key":"2020082913520932700_CIT0019","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/thx.2009.131532","article-title":"Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis","volume":"65","author":"Prayle","year":"2010","journal-title":"Thorax"},{"key":"2020082913520932700_CIT0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3947\/ic.2015.47.4.239","article-title":"The incidence and clinical characteristics of acute serum creatinine elevation more than 1.5 mg\/dL among the patients treated with tenofovir\/emtricitabine-containing HAART regimens","volume":"47","author":"Jin","year":"2015","journal-title":"Infect Chemother"},{"key":"2020082913520932700_CIT0021","doi-asserted-by":"crossref","first-page":"52","DOI":"10.7196\/SAMJ.2016.v106i4.10153","article-title":"Clinician compliance with laboratory monitoring and prescribing guidelines in HIV-1-infected patients receiving tenofovir","volume":"106","author":"De Waal","year":"2016","journal-title":"S Afr Med J"},{"key":"2020082913520932700_CIT0022","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4102\/sajhivmed.v12i1.214","article-title":"The risks of concurrent treatment with tenofovir and aminoglycosides in patients with HIV-associated tuberculosis","volume":"12","author":"Kenyon","year":"2011","journal-title":"South Afr J HIV Med"},{"key":"2020082913520932700_CIT0023","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tube.2015.11.010","article-title":"Tuberculosis as a three-act play: a new paradigm for the pathogenesis of pulmonary tuberculosis","volume":"97","author":"Hunter","year":"2016","journal-title":"Tuberculosis (Edinb)"},{"key":"2020082913520932700_CIT0024","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1743-7075-6-50","article-title":"Pathophysiological changes that affect drug disposition in protein-energy malnourished children","volume":"6","author":"Oshikoya","year":"2009","journal-title":"Nutr Metab (Lond)"},{"key":"2020082913520932700_CIT0025","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1128\/AAC.39.2.545","article-title":"Aminoglycoside dosing weight correction factors for patients of various body sizes","volume":"39","author":"Traynor","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"2020082913520932700_CIT0026","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00228-010-0851-0","article-title":"A systematic review of pharmacokinetics studies in children with protein-energy malnutrition","volume":"66","author":"Oshikoya","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"2020082913520932700_CIT0027","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2014.07.006","article-title":"The effect of pathophysiology on pharmacokinetics in the critically ill patient\u2014concepts appraised by the example of antimicrobial agents","volume":"77","author":"Blot","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"2020082913520932700_CIT0028","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/sj.ejcn.1600830","article-title":"Antioxidant status in children with protein-energy malnutrition (PEM) living in Cairo, Egypt","volume":"53","author":"Ashour","year":"1999","journal-title":"Eur J Clin Nutr"},{"key":"2020082913520932700_CIT0029","first-page":"254396","article-title":"Free radica","volume":"2014","author":"Khare","year":"2014","journal-title":"Int J Pediatr"},{"key":"2020082913520932700_CIT0030","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/ar.22578","article-title":"Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention","volume":"295","author":"Schacht","year":"2012","journal-title":"Anat Rec (Hoboken)"},{"key":"2020082913520932700_CIT0031","volume-title":"Heari","author":"Tysome","year":"2016"},{"key":"2020082913520932700_CIT0032","doi-asserted-by":"crossref","first-page":"e111702","DOI":"10.1371\/journal.pone.0111702","article-title":"Development and evaluation of a pilot nurse case management model to address multidrug-resistant tuberculosis (MDR-TB) and HIV in South Africa","volume":"9","author":"Farley","year":"2014","journal-title":"PLoS One"},{"key":"2020082913520932700_CIT0033","volume-title":"Management of drug-resistant tuberculosis: policy guidelines","author":"Republic of South Africa Department of Health","year":"2013"},{"key":"2020082913520932700_CIT0034","volume-title":"Stata statistical software: release 15","author":"StataCorp","year":"2017"},{"key":"2020082913520932700_CIT0035","first-page":"1811","article-title":"Aminoglycosides: a practical review","volume":"58","author":"Gonzalez","year":"1998","journal-title":"Am Fam Physician"},{"key":"2020082913520932700_CIT0036","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1128\/AAC.00174-11","article-title":"Simplified estimation of aminoglycoside pharmacokinetics in underweight and obese adult patients","volume":"55","author":"Pai","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2020082913520932700_CIT0037","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3389\/fncel.2017.00308","article-title":"Aminoglycoside-induced cochleotoxicity: a review","volume":"11","author":"Jiang","year":"2017","journal-title":"Front Cell Neurosci"},{"key":"2020082913520932700_CIT0038","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1113\/jphysiol.2005.085951","article-title":"The aminoglycoside antibiotic dihydrostreptomycin rapidly enters mouse outer hair cells through the mechano-electrical transducer channels","volume":"567","author":"Marcotti","year":"2005","journal-title":"J Physiol"},{"key":"2020082913520932700_CIT0039","volume-title":"WHO treatment guidelines for multidrug- and rifampicin-resistant tuberculosis, 2018 update","author":"World Health Organization","year":"2018"},{"key":"2020082913520932700_CIT0040","author":"World Health Organization"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciz289\/28702174\/ciz289.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/70\/5\/917\/33697903\/ciz289.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/70\/5\/917\/33697903\/ciz289.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T17:23:00Z","timestamp":1598894580000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/70\/5\/917\/5432319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,4,8]]},"published-print":{"date-parts":[[2020,2,14]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciz289","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,3,1]]},"published":{"date-parts":[[2019,4,8]]}}}